Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 478641, 9 pages
http://dx.doi.org/10.1155/2014/478641
Research Article

Chemokine CXCL16 Expression Suppresses Migration and Invasiveness and Induces Apoptosis in Breast Cancer Cells

1Department of Radiation Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, 37 Guoxuexiang, Chengdu, Sichuan 610041, China
2University of Virginia School of Medicine, Charlottesville, VA 22908, USA

Received 27 January 2014; Revised 29 March 2014; Accepted 29 March 2014; Published 22 April 2014

Academic Editor: Ryu-Ichiro Hata

Copyright © 2014 Yeying Fang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Wilbanks, S. C. Zondlo, K. Murphy et al., “Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines,” The Journal of Immunology, vol. 166, no. 8, pp. 5145–5154, 2001. View at Google Scholar · View at Scopus
  2. M. Matloubian, A. David, S. Engel, J. E. Ryan, and J. G. Cyster, “A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo,” Nature Immunology, vol. 1, no. 4, pp. 298–304, 2000. View at Google Scholar · View at Scopus
  3. T. Shimaoka, N. Kume, M. Minami et al., “Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages,” The Journal of Biological Chemistry, vol. 275, no. 52, pp. 40663–40666, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. P. J. Gough, K. J. Garton, P. T. Wille, M. Rychlewski, P. J. Dempsey, and E. W. Raines, “A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16,” The Journal of Immunology, vol. 172, no. 6, pp. 3678–3685, 2004. View at Google Scholar · View at Scopus
  5. A. Ludwig, C. Hundhausen, M. H. Lambert et al., “Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules,” Combinatorial Chemistry & High Throughput Screening, vol. 8, no. 2, pp. 161–171, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. C. H. Kim, E. J. Kunkel, J. Boisvert et al., “Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential,” The Journal of Clinical Investigation, vol. 107, no. 5, pp. 595–601, 2001. View at Google Scholar · View at Scopus
  7. L. Deng, N. Chen, Y. Li, H. Zheng, and Q. Lei, “CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer,” Biochimica et Biophysica Acta: Reviews on Cancer, vol. 1806, no. 1, pp. 42–49, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. N. Wente, M. M. Gaida, C. Mayer et al., “Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma,” International Journal of Oncology, vol. 33, no. 2, pp. 297–308, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Lu, J. Wang, Y. Xu et al., “CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro,” Molecular Cancer Research, vol. 6, no. 4, pp. 546–554, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Wang, Y. Lu, J. Wang, A. E. Koch, J. Zhang, and R. S. Taichman, “CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway,” Cancer Research, vol. 68, no. 24, pp. 10367–10376, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Matsushita, Y. Toiyama, K. Tanaka et al., “Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients,” Annals of Surgical Oncology, vol. 19, supplement 3, pp. 518–527, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Hojo, K. Koizumi, K. Tsuneyama et al., “High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer,” Cancer Research, vol. 67, no. 10, pp. 4725–4731, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Gutwein, A. Schramme, N. Sinke et al., “Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients,” European Journal of Cancer, vol. 45, no. 3, pp. 478–489, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. C. DeSantis, R. Siegel, P. Bandi, and A. Jemal, “Breast cancer statistics, 2011,” CA: A Cancer Journal for Clinicians, vol. 61, no. 6, pp. 408–418, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. W.-L. Sun, J. Chen, Y.-P. Wang, and H. Zheng, “Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development,” Autophagy, vol. 7, no. 9, pp. 1035–1044, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Hirohashi and Y. Kanai, “Cell adhesion system and human cancer morphogenesis,” Cancer Science, vol. 94, no. 7, pp. 575–581, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. R. B. Hazan, G. R. Phillips, R. F. Qiao, L. Norton, and S. A. Aaronson, “Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis,” The Journal of Cell Biology, vol. 148, no. 4, pp. 779–790, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Darash-Yahana, J. W. Gillespie, S. M. Hewitt et al., “The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers,” PLoS ONE, vol. 4, no. 8, Article ID e6695, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Shimaoka, T. Nakayama, N. Fukumoto et al., “Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells,” Journal of Leukocyte Biology, vol. 75, no. 2, pp. 267–274, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Christofori and H. Semb, “The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene,” Trends in Biochemical Sciences, vol. 24, no. 2, pp. 73–76, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. T. M. Handel, Z. Johnson, S. E. Crown, E. K. Lau, M. Sweeney, and A. E. Proudfoot, “Regulation of protein function by glycosaminoglycans—as exemplified by chemokines,” Annual Review of Biochemistry, vol. 74, pp. 385–410, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Ali, A. C. V. Palmer, B. Banerjee, S. J. Fritchley, and J. A. Kirby, “Examination of the function of RANTES, MIP-1α, and MIP-1β following interaction with heparin-like glycosaminoglycans,” The Journal of Biological Chemistry, vol. 275, no. 16, pp. 11721–11727, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Sadir, F. Baleux, A. Grosdidier, A. Imberty, and H. Lortat-Jacob, “Characterization of the stromal cell-derived factor-1α-heparin complex,” The Journal of Biological Chemistry, vol. 276, no. 11, pp. 8288–8296, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. J. L. de Paz, E. A. Moseman, C. Noti, L. Polito, U. H. von Andrian, and P. H. Seeberger, “Profiling heparin—chemokine interactions using synthetic tools,” ACS Chemical Biology, vol. 2, no. 11, pp. 735–744, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. R. U. Jänicke, M. L. Sprengart, M. R. Wati, and A. G. Porter, “Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis,” The Journal of Biological Chemistry, vol. 273, no. 16, pp. 9357–9360, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. L.-P. Weng, W. M. Smith, P. L. M. Dahia et al., “PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death,” Cancer Research, vol. 59, no. 22, pp. 5808–5814, 1999. View at Google Scholar · View at Scopus
  28. D. T. T. Chua, J. M. Nicholls, J. S. T. Sham, and G. K. H. Au, “Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy,” International Journal of Radiation, Oncology, Biology, Physics, vol. 59, no. 1, pp. 11–20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Prenzel, O. M. Fischer, S. Streit, S. Hart, and A. Ullrich, “The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification,” Endocrine-Related Cancer, vol. 8, no. 1, pp. 11–31, 2001. View at Publisher · View at Google Scholar · View at Scopus